Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial.

Autor: Weinblatt, Michael E., Keystone, Edward C., Furst, Daniel E., Moreland, Larry W., Weisman, Michael H., Birbara, Charles A., Teoh, Leah A., Fischkoff, Steven A., Chartash, Elliot K.
Zdroj: Arthritis & Rheumatism; Jan2003, Vol. 48 Issue 1, p35-45, 11p
Databáze: Complementary Index
Externí odkaz: